Scholarlink

Background <p>Proenkephalin A 119–159 (penKid) is a functional kidney biomarker inversely correlating with the glomerular filtration rate. We conducted a patient-level meta-analysis to evaluate whether penKid provides additional value to serum creatinine (sCr) for assessing kidney function and outcome in patients with sepsis or septic shock.</p> Methods <p>To identify eligible studies, the database PubMed and internal resources have been searched in March 2025. Randomized controlled trials or observational trials enrolling patients with sepsis or septic shock admitted to ICU (&gt; 100 patients per study) were included. The primary endpoint was worsening renal function (WRF) defined as a further increase of sCr equal or greater 0.3&#xa0;mg/dL within 48&#xa0;h from ICU admission value (baseline), or need for renal replacement therapy (RRT) or death within 48&#xa0;h. Secondary endpoint was 28d-mortality. Subgroups were created applying upper normal reference values for penKid and sCr.</p> Results <p>Individual data from 2,203 patients with sepsis or septic shock enrolled in four studies were included. penKid was independently associated with WRF (OR 3.4, 95% CI 2.7–4.3, <i>p</i> &lt; 0.0001) and 28d-mortality (OR 1.6, 95% CI 1.4–1.9, <i>p</i> &lt; 0.0001). Among patients with normal sCr at admission, those with elevated penKid had a higher incidence of WRF compared to patients with normal penKid (27.1% vs. 11.1%, <i>p</i> &lt; 0.0001) and the highest 28d-mortality (38.6% vs. 15.3%, <i>p</i> &lt; 0.0001).</p> Conclusion <p>penKid adds predictive value beyond sCr for identifying patients at risk for WRF and 28d-mortality. Importantly, elevated penKid identifies at-risk patients even when sCr is normal. Combining both biomarkers may therefore offer a valuable tool for risk stratification in patients with sepsis or septic shock.</p> Trial registration <p>This meta-analysis has been retrospectively registered at PROSPERO, CRD420251153702. Registered 23 September 2025.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical utility of proenkephalin A 119-159 for prediction of worsening renal function and prognosis in patients with sepsis –results of a patient-level meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月24日

查看全文
  • Birte Arlt,
  • Pietro Caironi,
  • Jennifer Meessen,
  • Oliver Hartmann,
  • Alexandre Mebazaa,
  • Matthieu Legrand,
  • Etienne Gayat,
  • Christian Nusshag,
  • Thorsten Brenner,
  • Pierre François Laterre,
  • Ornella Tinelli,
  • Roberto Latini,
  • Florian Uhle

摘要

Background

Proenkephalin A 119–159 (penKid) is a functional kidney biomarker inversely correlating with the glomerular filtration rate. We conducted a patient-level meta-analysis to evaluate whether penKid provides additional value to serum creatinine (sCr) for assessing kidney function and outcome in patients with sepsis or septic shock.

Methods

To identify eligible studies, the database PubMed and internal resources have been searched in March 2025. Randomized controlled trials or observational trials enrolling patients with sepsis or septic shock admitted to ICU (> 100 patients per study) were included. The primary endpoint was worsening renal function (WRF) defined as a further increase of sCr equal or greater 0.3 mg/dL within 48 h from ICU admission value (baseline), or need for renal replacement therapy (RRT) or death within 48 h. Secondary endpoint was 28d-mortality. Subgroups were created applying upper normal reference values for penKid and sCr.

Results

Individual data from 2,203 patients with sepsis or septic shock enrolled in four studies were included. penKid was independently associated with WRF (OR 3.4, 95% CI 2.7–4.3, p < 0.0001) and 28d-mortality (OR 1.6, 95% CI 1.4–1.9, p < 0.0001). Among patients with normal sCr at admission, those with elevated penKid had a higher incidence of WRF compared to patients with normal penKid (27.1% vs. 11.1%, p < 0.0001) and the highest 28d-mortality (38.6% vs. 15.3%, p < 0.0001).

Conclusion

penKid adds predictive value beyond sCr for identifying patients at risk for WRF and 28d-mortality. Importantly, elevated penKid identifies at-risk patients even when sCr is normal. Combining both biomarkers may therefore offer a valuable tool for risk stratification in patients with sepsis or septic shock.

Trial registration

This meta-analysis has been retrospectively registered at PROSPERO, CRD420251153702. Registered 23 September 2025.